Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

Clinical trial NCT07258641 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07258641
Sponsor: University Medical Center Groningen
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)Crohn Disease (CD)

Start date: 2026-01-15
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.